Results of a Phase II Study of Guadecitabine in Higher Risk MDS Patients Refractory to or Relapsing after Azacitidine Treatment. (April 2017)

Record Type:
Journal Article
Title:
Results of a Phase II Study of Guadecitabine in Higher Risk MDS Patients Refractory to or Relapsing after Azacitidine Treatment. (April 2017)
Main Title:
Results of a Phase II Study of Guadecitabine in Higher Risk MDS Patients Refractory to or Relapsing after Azacitidine Treatment
Authors:
Sebert, M.
Bally, C.
Peterlin, P.
Beyne-Rauzy, O.
Legros, L.
Gourin, M.P.
Sanhes, L.
Wattel, E.
Gyan, E.
Park, S.
Stamatoullas, A.
Laribi, K.
Banos, A.
Jueliger, S.
Chevret, S.
Ades, L.
Fenaux, P.
Abstract:
Is Part Of:
Leukemia research. Volume 55(2017)Supplement 1
Journal:
Leukemia research
Issue:
Volume 55(2017)Supplement 1
Issue Display:
Volume 55, Issue 1 (2017)
Year:
2017
Volume:
55
Issue:
1
Issue Sort Value:
2017-0055-0001-0000
Page Start:
S54
Page End:
Publication Date:
2017-04
Subjects:
Leukemia -- Periodicals
Leukemia -- Periodicals
Leucémie -- Périodiques
Leukemia
Periodicals
Electronic journals
Electronic journals
616.9941905
Journal URLs:
http://www.sciencedirect.com/science/journal/01452126 ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/S0145-2126(17)30198-4 ↗
Languages:
English
ISSNs:
0145-2126
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 5185.270000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
439.xml